Analysis of the impact of COVID-19 on major depressive disorder in adults: a systematic review
DOI:
https://doi.org/10.34119/bjhrv7n4-244Keywords:
COVID-19, pandemic, mental health, depressive disorderAbstract
The COVID-19 pandemic has had a multifaceted impact on people's daily lives and has adversely affected the population's mental health in several aspects. Therefore, the objective of this study is to analyze the impact of COVID-19 on the prevalence of major depressive disorder in adults, aiming to summarize the current literature to provide a broader understanding of the topic in pre- and post-pandemic scenarios. For this purpose, a literature review was conducted between October 2023 and February 2024, based on articles published in health databases. The PRISMA method and the PECO strategy were employed alongside the GRADE methodology to analyze the evidence. The study found that while the prevalence of depressive disorders varied geographically, there was a significant global increase due to the pandemic. After a worldwide peak in diagnoses, incidence rates tend to stabilize; however, it is important to note that some sequelae may persist in more vulnerable individuals or those who have contracted COVID-19. In summary, the adverse effects on mental health following the pandemic were evident, with health system responses influencing how countries addressed this increase, underscoring the importance of prioritizing mental health as a public health issue.
References
AMERICAN PSYCHIATRIC ASSOCIATION (APA). Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. Washington DC: APA, 2019.86p.
AMERICAN PSYCHIATRIC ASSOCIATION (APA). Manual diagnóstico e estatístico de transtornos mentais: DSM-5. 5. ed. Porto Alegre: Artmed, 2013. 992p.
BARROS, M.B.A. et al. Depressão e comportamentos de saúde em adultos brasileiros – PNS 2013. Rev Saúde Pública, v. 51, p. 1-10, 2017.
BERKMAN, L.F.; SYME, S.L. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol., v. 109, n. 2, p. 186-204, 1979.
BRITO, V.C.A. et al. Prevalência de depressão autorreferida no Brasil: Pesquisa Nacional de Saúde 2019 e 2013. Epidemiol Serv Saúde, v. 31, p; 1-13, 2022.
CACIOPPO, J.; PATRICK, W. Loneliness: Human Nature and the Need for Social Connection. Amer J Psychiat., v. 166, 2008.
CAMPOS, F.A.A.C.; RODRÍGUEZ, T.D.M.; FEITOSA, F.B. Avaliação de conteúdo do Protocolo de Diagnóstico da Depressão em Adulto (PDDA). J Health NPEPS., p. 1-14, 2022.
CARR, M.J. et al. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study. Lancet Public Health, v. 6, n. 2, p. 1-28, 2021.
CHARUL, J.R. et al. COVID and depression among stratified population groups: a narrative review. Eur J Med Res., v. 28, n. 265, p. 1-13, 2023.
CHEN, P.J. et al. An overview of mental health during the COVID-19 pandemic. Diagnosis., v. 8, n. 4, p. 403-12, 2021.
COULAUD, P-j. et al. Association between level of compliance with COVID-19 public health measures and depressive symptoms: A cross-sectional survey of young adults in Canada and France. Plos one., v. 18, n. 8, p. 1-20, 2023.
DAMIAN, R.F. et al. Post-COVID-19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study. Gen Hosp Psychiatry., v. 75, p. 38-45, 2022.
FICO, G. et al. Anxiety and depression played a central role in the COVID-19 mental distress: A network analysis. J Affect., v. 338, p. 384-92, 2023.
HARRISON, P.J.; TAQUET M. Neuropsychiatric disorders following SARS-CoV-2 infection. Brain., v. 146, n. 6, p. 2241-47, 2023.
HAWKLEY, L.C.; CACIOPPO, J. Loneliness matters: a theoretical and empirical review of consequences and mechanisms. Ann Behav Med., v. 40, n. 2, p. 218-227, 2010.
HOUSE, J.S.; LANDIS, K.R.; UMBERSON D. Social relationships and health. Science, v. 241, n. 4865, p. 540-545, 1988.
JENSEN, P. et al. Incidence rates of treated mental disorders before and during the COVID-19 pandemic—a nationwide study comparing trends in the period 2015 to 2021. BMC Psychiatry., v. 23, n. 668, p. 1-13, 2023.
KARPOV, M.V. et al. Exploring the influence of behavioral factors on depression and anxiety scores during the COVID-19 pandemic: insights from the Virginia statewide COVIDsmart longitudinal study. BMC Public Health., v. 23, n. 1749, p. 1-13, 2023.
KUMAR, A.; NAYAR, R. COVID 19 and its mental health consequences. J Ment Health., v. 30, p. 1-2, 2020.
LEUNG, O. et al. Dimensional structure of one‐year post‐COVID‐19 neuropsychiatric and somatic sequelae and association with role impairment. Sci Rep., v. 13, n. 12205, p. 1-11, 2023.
MOREIRA, R.P. et al. Relationship between neuropsychiatric signs and symptoms and SARS-CoV-2 infection: a systematic review. Authorea., p. 1-20, 2020.
ORGANIZAÇÃO PAN-AMERICANA DA SAÚDE (OPAS). Depressão. Escritório Regional para as Américas da Organização Mundial da Saúde, 2023.
ROGERS, J.P. et al. Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives. J Neurol Neurosurg Psychiatry., v. 92, n. 9, p. 932-941, 2021.
RUSSELL, D. et al. Social and emotional loneliness: an examination of Weiss's typology of loneliness. J Pers Soc Psychol., v. 46, n. 6, p. 1313-1321, 1984.
SANTOMAURO, D.F. et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet Public Health, v. 397, n. 10312, p. 1700-12, 2021.
SUEN, P.J.C. et al. Examining the impact of the COVID-19 pandemic through the lens of the network approach to psychopathology: Analysis of the Brazilian Longitudinal Study of Health (ELSA-Brasil) cohort over a 12-year timespan. J. Anxiety Disord., v. 85, n. 102512, 2022.
VALLIS, E.H. et al. Depressive symptoms in youth before and during the COVID-19 pandemic: longitudinal investigation of patterns dependent on age, sex, and family history of mental illness. Psychol Med., p. 1-7, 2023.
WANG, J. et al. Study problems and depressive symptoms in adolescents during the COVID-19 outbreak: poor parent-child relationship as a vulnerability. Globalization and Health, v. 17, n. 40, p. 1-9, 2021.
WORLD HEALTH ORGANIZATION (WHO). COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide. Genebra: WHO, 2022.
WORLD HEALTH ORGANIZATION (WHO). Depression and Other Common Mental Disorders: Global Health Estimates. Genebra: WHO, 2017. 24p.
WORLD HEALTH ORGANIZATION (WHO). The WHO special initiative for mental health (2019-2023). Genebra: WHO, 2019.
XU, D. et al. A Scientometrics Analysis and Visualization of Depressive Disorder. Curr Neuropharmacol., v. 19, n. 6, p. 766-86, 2021.
